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This paper presents the data on the optimisation and validation of
a liquid chromatography-high-resolution mass spectrometry (LC-
HRMS) to establish the presence of phosphodiesterase 5 (PDE5) in-
hibitors and their analogues as adulterants in instant coffee premixes.
The method development data covered chromatographic optimisa-
tion for better analyte separation and isomeric resolution, mass
spectrometry optimisation for high sensitivity and sample prepara-
tion optimisation for high extraction recovery (RE) and low matrix
effect (ME). The validation data covered specificity, linearity, range,
accuracy, limit of detection, limit of quantification, precisions,ME, and
RE. The optimisation and validation data presented here is related to
the article: “Determination of phosphodiesterase 5 (PDE5) inhibitors
in instant coffee premixes using liquid chromatography-high-
resolution mass spectrometry (LC-HRMS)” Mohd Yusop et al., 2019.
© 2019 The Authors. Published by Elsevier Inc. This is an open
access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).j.talanta.2019.05.078.
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Specifications table
Subject Chemistry
Specific subject area Analytical chemistry
Type of data Table and extracted ion chromatograms (EICs)
How data was acquired Liquid chromatography-high-resolution mass spectrometry (LC-HRMS) Agilent Technologies
(Santa Clara, CA, USA) 1290 Infinity II LC system coupled to Agilent Technologies 6510
quadrupole time of flight-mass spectrometer (QTOF-MS)
Data format Extracted and analysed LC-HRMS data
Parameters for
data collection
Extraction of analyte-free blank instant coffee premix using dilute and shoot technique with
methanol and modified quick, easy, cheap, effective, rugged, and safe (QuEChERS) procedure
Description of
data collection
Liquid chromatography-high-resolution mass spectrometry (LC-HRMS) for the determination
of phosphodiesterase 5 (PDE5) inhibitors and their analogues as adulterants in instant
coffee premixes
Data source location Institution: University of Technology Sydney
City/Town/Region: Ultimo, NSW, 2007
Country: Australia
Latitude and longitude for collected data: 33.8832 S, 151.2005 E
Data accessibility Data are available with this article
Related research article A.Y. Mohd Yusop, L. Xiao, S. Fu, Determination of phosphodiesterase 5 (PDE5) inhibitors in
instant coffee premixes using liquid chromatography-high-resolution mass spectrometry
(LC-HRMS), Talanta 204 (2019) 36e43. https://doi.org/10.1016/j.talanta.2019.05.078
Value of the data
 The comprehensive optimisation procedures presented in this paper are valuable for those working on LC-HRMS method
development, especially for complex matrices.
 Optimisation of chromatography, sample extraction, and sample dilution are the key to the minimisation of matrix effect.
 The validation data would serve as a reference for forensic drug testing laboratories working on a similar aim of combating
adulterated consumable products.
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Fig. 1 shows the chromatographic separation of four different groups of structural isomers of
phosphodiesterase 5 (PDE5) inhibitors displaying the extracted ion chromatograms (EICs) of the
protonated molecule ([MþH]þ) precursor ions. Table 1 presents the comparison of matrix effect (ME)
for instant coffee premix matrix using different extraction technique while Tables 2e4 summarise the
validation data of the analytical method. The optimisation of the analytical method additionally
described in this paper.
2. Experimental design, materials, and methods
The detail on the chemicals and reagents, standard solution and blank matrix preparation, and data
analysis are described in [1].2.1. Sample preparation
Thewhole content of an instant coffee premix sachet was weighed into a 50 mL polypropylene tube
and recorded. Then,100mg of the powder was weighed into a 15mL polypropylene tube and dissolved
in 5 mL of acetonitrile and methanol (50:50, v/v), followed by vortex mixing for 1 minute, sonication
for 20minutes, and centrifugation for 5minutes at 2500g, successively. Thewhole upper solutionwas
then transferred into another 50 mL polypropylene tube prefilled with half of a sachet of the Restek Q-
sep QuEChERS salts. Immediately, the sample solution was vortexed for 1 minute followed by centri-
fugation for 5 minutes at 2500g to separate the solid extraction salts. The upper layer was filtered
using a 0.22 mm PTFE syringe filter and then diluted with methanol at 1:10 dilution level for analysis.
The blank instant coffee premix was treated in the same manner as the steps described for the sample
analysis. For quantification purpose, whenever the analyte concentration was beyond the linear range,
Fig. 1. Chromatographic separation of structural isomers with EICs of the [MþH]þ precursor ions of: Group A (m/z 439.2452):
desmethylcarbodenafil (1) and N-desethylacetildenafil (3); Group B (m/z 467.2765): acetildenafil (4) and dimethylacetildenafil (6);
Group C (m/z 489.2279): vardenafil (7), homosildenafil (9), dimethylsildenafil (10), and propoxyphenyl-sildenafil (13); and Group D
(m/z 505.2050): thiohomosildenafil (19) and thiodimethylsildenafil (21).
A.Y. Mohd Yusop et al. / Data in brief 25 (2019) 104234 3the sample solution was further diluted with methanol to fit the resulting concentration within the
range of the constructed external calibration curve.
2.2. LC-HRMS conditions
The chromatographic separation was performed using an Agilent Technologies (Santa Clara, CA,
USA) 1290 Infinity II LC system coupled to an Agilent Technologies 6510 quadrupole time of flight-massTable 1
ME for instant coffee premix using D&S technique with methanol and modified QuEChERS procedure at three levels of dilution.
No. Analytes ME (%) (n ¼ 9)
Dilution 1:2 Dilution 1:10 Dilution 1:100
D&S QuEChERS D&S QuEChERS D&S QuEChERS
1 Desmethylcarbodenafil 19.7 9.8 6.4 þ1.2 0.9 0.2
2 Carbodenafil 21.1 9.7 5.1 þ1.0 þ0.3 0.0
3 N-desethylacetildenafil 95.4 23.3 62.3 þ0.1 þ1.7 þ1.5
4 Acetildenafil 100.0 36.7 73.0 5.2 1.7 þ0.3
5 Hydroxyvardenafil 3.4 6.1 þ4.8 þ5.3 þ0.7 þ2.7
6 Dimethylacetildenafil 96.7 22.7 63.9 2.9 3.3 þ1.2
7 Vardenafil 2.9 8.9 þ1.5 þ0.2 1.1 0.4
8 Sildenafil 19.3 11.8 4.4 þ1.3 0.0 þ1.9
9 Homosildenafil 23.0 9.5 8.4 þ1.4 1.9 þ0.7
10 Dimethylsildenafil 18.2 6.0 5.6 þ5.3 2.2 þ3.1
11 Propoxyphenyl-hydroxyhomosildenafil 12.9 6.7 2.7 þ5.6 þ0.1 þ4.4
12 Udenafil 15.2 10.5 4.3 þ2.1 0.5 þ1.0
13 Propoxyphenyl-sildenafil 20.7 13.1 8.3 0.5 3.1 þ1.1
14 Hydroxythiovardenafil 14.0 10.1 1.9 þ5.4 1.5 þ3.4
15 Tadalafil 23.3 9.4 10.2 þ3.4 1.9 þ3.2
16 Mirodenafil 14.6 9.4 3.9 þ1.0 2.2 þ1.4
17 Mutaprodenafil 11.8 10.1 3.5 þ2.1 1.7 þ0.2
18 Thiosildenafil 15.9 7.1 3.2 þ5.1 3.0 þ3.6
19 Thiohomosildenafil 21.4 12.1 5.4 þ5.6 2.9 þ3.0
20 Dithiodesmethylcarbodenafil 10.6 8.9 2.9 4.9 0.2 þ0.2
21 Thiodimethylsildenafil 24.0 11.3 4.2 þ8.7 2.6 þ3.8
22 Propoxyphenyl-thiohydroxyhomosildenafil 9.0 2.8 þ3.6 þ7.3 1.4 þ5.8
23 Propoxyphenyl-thiodimethylsildenafil 22.7 6.9 4.8 þ6.4 2.9 þ4.2
Table 2














1 Desmethylcarbodenafil 8.78 439.2452 439.2452 0.00 311.1139 339.1452
2 Carbodenafil 9.23 453.2609 453.2600 1.96 311.1139 339.1452
3 N-desethylacetildenafil 9.65 439.2452 439.2454 0.46 325.1295 297.1346
4 Acetildenafil 10.62 467.2765 467.2764 0.21 127.1230 111.0917
5 Hydroxyvardenafil 10.80 505.2228 505.2222 1.19 312.1581 151.0866
6 Dimethylacetildenafil 11.17 467.2765 467.2763 0.43 325.1295 127.1230
7 Vardenafil 11.39 489.2279 489.2276 0.61 312.1581 151.0866
8 Sildenafil 13.38 475.2122 475.2119 0.63 283.1190 100.0995
9 Homosildenafil 13.99 489.2279 489.2274 1.02 283.1190 113.1073
10 Dimethylsildenafil 14.77 489.2279 489.2279 0.00 283.1190 113.1073
11 Propoxyphenyl-hydroxyhomosildenafil 15.74 519.2384 519.2391 1.35 129.1022 283.1190
12 Udenafil 15.99 517.2592 517.2594 0.39 283.1190 112.1121
13 Propoxyphenyl-sildenafil 16.16 489.2279 489.2286 1.43 100.0995 283.1190
14 Hydroxythiovardenafil 18.36 521.1999 521.2000 0.19 328.1352 167.0637
15 Tadalafil 20.63 390.1448 390.1444 1.03 169.0760 268.1081
16 Mirodenafil 21.59 532.2588 532.2588 0.00 312.1343 296.1394
17 Mutaprodenafil 21.81 630.2275 630.2275 0.00 113.1073 142.0070
18 Thiosildenafil 24.96 491.1894 491.1886 1.63 100.0995 299.0961
19 Thiohomosildenafil 25.99 505.2050 505.2049 0.20 299.0961 113.1073
20 Dithiodesmethylcarbodenafil 26.26 471.1995 471.1994 0.21 343.0682 371.0995
21 Thiodimethylsildenafil 26.81 505.2050 505.2048 0.40 113.1073 299.0961
22 Propoxyphenyl-thiohydroxyhomosildenafil 27.48 535.2156 535.2155 0.19 129.1022 299.0961
23 Propoxyphenyl-thiodimethylsildenafil 30.36 519.2207 519.2210 0.58 113.1073 299.0961
A.Y. Mohd Yusop et al. / Data in brief 25 (2019) 1042344spectrometer (QTOF-MS) equipped with a dual electrospray ionisation (ESI) nebuliser. The LC system
was fitted with a reverse phase high-performance LC column fromMerck KGaA (Darmstadt, Germany)
Chromolith® High-Resolution RP-18 end-capped (100  4.6 mm, 2.0 mm) with column compartment
temperature maintained at 20 C.
The binary mobile phase composition comprised solvent A (10 mM ammonium formate in
ultrapurewater) and solvent B (acetonitrile). Both solvents were acidifiedwith 0.1% v/v formic acid. The
gradient elution was initiated at 5% B and held for 1 minute, followed by a linear boost for 1 minute to
25% B. It was then slowly ramped up to 50% B for 30 minutes followed by a linear boost to 95% B for 1
minute. For the isocratic hold at high organic solvent, 95% B was held for 1 minute before immediately
returning the system at 34.01 minutes to the initial gradient of 5% B for 6 minutes. The flow rate was
maintained at 0.4 mL/min for the first 34 minutes before immediately ramping it to 1 mL/min between
34.01 and 40 minutes. Post-run equilibration was maintained at 0.4 mL/min for 5 minutes before the
next injection. The injection volume was set for 5 mL with the autosampler compartment temperature
maintained at 10 C.
The QTOF-MS was operated at a low mass range of m/z 1700, calibrated before each chromato-
graphic run to achieve an excellent mass accuracy. ESI in positive ionisation mode was employed with
flow-dependent source parameters set at 300 C for gas temperature, 12 L/min for drying gas flow,
and 32 psig for nebuliser pressure. The compound-dependent source parameters were set at 3500 V
for capillary voltage and 175 V for fragmentor voltage. Other common source parameters were
maintained at 65 V for skimmer voltage and 750 V for OCT 1 RF Vpp. An auto MS/MS acquisition was
selected for simultaneous MS and MS/MS experiments within a mass range of m/z 100 to 1100. The
acquisition rates were set at 1 and 3 spectra/s for the MS and MS/MS experiments, respectively, with
a narrow isolation width of m/z ~1.3. For the fragmentation of the [MþH]þ precursor ion, the collision
energy (CE) was fixed at 10, 20, and 40 eV in a separate scan with nitrogen as the collision gas.
The reference mass solution was continuously infused through the reference nebuliser at a steady
pressure of 5 psig.
Table 3
Coefficient of determination, accuracy, limit of detection (LOD), and limit of quantification (LOQ) of 23 targeted PDE5 inhibitors.
No. Analytes Coefficient of
determination
(r2)





1 Desmethylcarbodenafil 0.9979 116.5 ± 3.4 102.9 ± 1.9 108.8 ± 2.2 10 80
2 Carbodenafil 0.9982 119.3 ± 1.1 100.4 ± 2.8 107.8 ± 1.6 10 80
3 N-desethylacetildenafil 0.9980 105.8 ± 2.5 96.6 ± 4.1 104.1 ± 2.8 30 80
4 Acetildenafil 0.9969 106.3 ± 0.4 106.8 ± 6.4 100.6 ± 1.7 20 80
5 Hydroxyvardenafil 0.9985 103.5 ± 2.2 108.8 ± 3.2 108.6 ± 1.5 10 80
6 Dimethylacetildenafil 0.9960 117.5 ± 3.0 94.8 ± 3.8 109.2 ± 1.9 20 80
7 Vardenafil 0.9972 94.8 ± 1.2 110.3 ± 1.4 107.0 ± 1.2 20 80
8 Sildenafil 0.9989 110.9 ± 1.3 101.0 ± 1.6 109.3 ± 1.5 30 80
9 Homosildenafil 0.9993 108.3 ± 1.0 105.8 ± 1.1 107.3 ± 1.2 40 80
10 Dimethylsildenafil 0.9989 116.5 ± 0.8 103.5 ± 1.2 107.7 ± 0.8 30 80
11 Propoxyphenyl-hydroxyhomosildenafil 0.9984 116.8 ± 3.6 103.2 ± 1.4 107.9 ± 2.4 70 80
12 Udenafil 0.9994 109.2 ± 1.9 105.8 ± 1.2 108.0 ± 1.4 10 80
13 Propoxyphenyl-sildenafil 0.9988 106.2 ± 1.0 107.4 ± 2.4 107.3 ± 1.6 10 80
14 Hydroxythiovardenafil 0.9984 98.5 ± 1.6 107.8 ± 1.0 107.5 ± 0.7 20 80
15 Tadalafil 0.9983 119.2 ± 4.4 106.5 ± 1.8 107.0 ± 3.1 60 80
16 Mirodenafil 0.9963 117.3 ± 1.4 101.6 ± 2.4 106.5 ± 0.7 10 80
17 Mutaprodenafil 0.9977 88.1 ± 1.6 108.4 ± 1.6 107.3 ± 1.4 20 80
18 Thiosildenafil 0.9972 97.5 ± 1.9 109.0 ± 1.6 107.6 ± 1.4 30 80
19 Thiohomosildenafil 0.9972 97.5 ± 1.5 109.6 ± 1.7 106.9 ± 1.9 10 80
20 Dithiodesmethylcarbodenafil 0.9960 90.7 ± 2.5 109.9 ± 1.3 106.7 ± 2.0 10 80
21 Thiodimethylsildenafil 0.9992 107.4 ± 2.2 105.2 ± 2.1 106.8 ± 0.8 20 80
22 Propoxyphenyl-
thiohydroxyhomosildenafil
0.9986 104.3 ± 2.8 109.2 ± 1.2 108.4 ± 0.6 20 80
23 Propoxyphenyl-thiodimethylsildenafil 0.9989 106.9 ± 4.9 105.1 ± 1.6 108.6 ± 1.2 10 80
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The simultaneous separation of a multi-analyte analysis can be a difficult task. Critical attention
must be given for each target analyte to achieve an excellent chromatographic separation for reliable
screening, identification, and quantification. The presence of four different groups of structural isomers
with their [MþH]þ precursor ions, i.e. Group A (m/z 439.2452): desmethylcarbodenafil (1) and
N-desethylacetildenafil (3); Group B (m/z 467.2765): acetildenafil (4) and dimethylacetildenafil (6);
Group C (m/z 489.2279): vardenafil (7), homosildenafil (9), dimethylsildenafil (10), and
propoxyphenyl-sildenafil (13); and Group D (m/z 505.2050): thiohomosildenafil (19) and thio-
dimethylsildenafil (21) among the 23 targeted PDE5 inhibitors need to be addressed to achieve, if
possible, an acceptable baseline chromatographic separation. Furthermore, matrix components from
the instant coffee premix may cause a significant ME and impair the overall analytical method per-
formance. Thus, the chromatographic separation will be optimised to resolve these issues apart from
achieving a good peak shape and resolution, and reproducible retention time.
During the early stage of method development, the suitability and performance of two different
columns were assessed using the initial scouting method. Both columns are of reverse phase but with
slightly different specifications. The first column tested was Nucleoshell RP 18 (100  4.6 mm, 2.7 mm)
produced a very broad peak with severe peak tailing for most target analytes. The second column,
Chromolith® High Resolution RP-18 end-capped (100  4.6 mm, 2.0 mm), displayed an exceptional
narrow peak for almost all target analytes with peak asymmetry factor of less than 1.2 based on the
symmetrical shape of a Gaussian peak. Although both columns have identical length and internal
diameter, the reduction in the particle size of the Chromolith® column led to higher peak efficiencies
and thus was chosen for the final methodology.
Organic solvents such as acetonitrile and methanol [2,3] are widely utilised in the analysis of PDE5
inhibitors using LC-MS/MS technique, were initially assessed. Acetonitrile produced a good chro-
matographic separation for most target analytes compared to methanol and thus selected as the
organic mobile phase. Due to the presence of multiple basic amine groups within PDE5 inhibitors,
Table 4
Precisions, ME, and RE of 23 targeted PDE5 inhibitors.
No. Analytes Precisions (%RSD) (n ¼ 9) ME (%)
(n ¼ 9)
RE (Mean ± SD, %)
(n ¼ 3)
Repeatability Intermediate
Low Med High Low Med High Low Med High
1 Desmethylcarbodenafil 4.4 2.0 2.1 3.1 2.9 3.0 þ1.2 117.4 ± 6.1 112.5 ± 1.8 97.6 ± 1.1
2 Carbodenafil 1.4 3.1 1.5 5.3 4.1 1.7 þ1.0 115.1 ± 2.2 111.4 ± 0.9 100.3 ± 0.3
3 N-desethylacetildenafil 2.7 4.4 2.7 3.0 1.5 2.0 þ0.1 53.8 ± 0.8 65.1 ± 2.0 95.1 ± 0.6
4 Acetildenafil 0.4 6.2 1.7 6.7 7.7 9.1 5.2 87.3 ± 0.1 84.7 ± 0.4 111.0 ± 4.5
5 Hydroxyvardenafil 2.5 3.1 1.4 6.1 1.5 2.6 þ5.3 116.7 ± 2.6 116.6 ± 1.2 106.4 ± 0.4
6 Dimethylacetildenafil 3.4 4.3 1.8 1.4 2.1 1.0 2.9 85.1 ± 4.6 83.9 ± 4.4 89.1 ± 4.4
7 Vardenafil 1.2 1.2 1.1 2.3 2.6 2.9 þ0.2 123.0 ± 8.6 115.5 ± 1.8 108.9 ± 1.1
8 Sildenafil 1.7 1.7 1.4 5.6 3.1 2.6 þ1.3 113.7 ± 4.5 109.5 ± 1.2 103.9 ± 1.8
9 Homosildenafil 1.2 1.1 1.2 3.6 1.8 1.4 þ1.4 116.0 ± 5.4 110.1 ± 1.8 103.5 ± 0.8
10 Dimethylsildenafil 1.1 1.3 0.8 6.9 2.7 4.1 þ5.3 115.3 ± 6.0 109.0 ± 1.6 103.1 ± 0.5
11 Propoxyphenyl-
hydroxyhomosildenafil
4.5 1.5 2.3 7.2 7.3 5.5 þ5.6 117.3 ± 6.7 114.3 ± 0.6 99.1 ± 11.8
12 Udenafil 2.1 1.2 1.3 0.6 1.2 2.2 þ2.1 113.3 ± 2.8 109.4 ± 1.2 102.3 ± 1.6
13 Propoxyphenyl-sildenafil 1.1 2.3 1.5 6.2 3.2 1.6 0.5 123.5 ± 0.2 120.4 ± 2.2 108.5 ± 0.6
14 Hydroxythiovardenafil 1.6 1.0 0.6 4.0 2.2 2.3 þ5.4 111.1 ± 1.4 109.4 ± 1.8 107.7 ± 0.3
15 Tadalafil 7.2 1.9 3.1 6.7 1.4 1.1 þ3.4 103.5 ± 8.3 101.5 ± 4.0 99.3 ± 2.2
16 Mirodenafil 2.0 2.6 0.7 2.3 2.7 3.1 þ1.0 111.0 ± 3.4 109.7 ± 1.5 103.5 ± 1.3
17 Mutaprodenafil 1.7 1.4 1.3 1.2 1.3 0.5 þ2.1 119.6 ± 5.6 112.0 ± 1.5 105.9 ± 0.9
18 Thiosildenafil 2.3 1.5 1.3 3.6 1.9 0.9 þ5.1 114.2 ± 4.6 108.8 ± 0.6 107.1 ± 1.4
19 Thiohomosildenafil 1.6 1.6 1.8 1.7 1.6 1.1 þ5.6 114.1 ± 3.7 106.7 ± 0.9 110.1 ± 1.9
20 Dithiodesmethylcarbodenafil 2.4 1.1 1.9 6.6 1.3 0.5 4.9 111.9 ± 2.1 105.6 ± 5.2 107.2 ± 5.2
21 Thiodimethylsildenafil 3.1 2.2 0.8 1.7 1.9 1.7 þ8.7 113.4 ± 3.9 107.0 ± 0.4 112.9 ± 0.5
22 Propoxyphenyl-
thiohydroxyhomosildenafil
3.9 1.2 0.6 5.7 2.1 4.1 þ7.3 111.0 ± 4.0 110.6 ± 1.5 109.4 ± 1.6
23 Propoxyphenyl-
thiodimethylsildenafil
7.3 1.7 1.2 1.0 0.6 1.4 þ6.4 111.0 ± 4.2 107.1 ± 0.8 104.8 ± 1.2
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both neutral and ionised forms. Therefore, the pKa values of these target analytes were first evaluated
using ChemAxon (Budapest, Hungary) software which revealed some significant variations depending
on their chemical structure. Taking all these pKa values into consideration led to the selection of
ammonium formate as a matrix modifier attributable to its pKa values and useful pH range, and its
superior volatility, which is essential for LC-MS/MS analysis. The ammonium formate was assessed at
three different concentrations of 5, 10, and 20mM. The 10mM buffer solution proved to be adequate to
achieve reproducible retention and improved separation with excellent peak shape and resolution for
all target analytes in the presence of 0.1% v/v formic acid in the mobile phases.
The elution profile covered 5%e95% of the organic solvent to account for the suspected-target and
non-targeted screening approaches. Also, the chromatographic gap at the first quarter of the runtime
permitted any highly polar and unretained matrix components to be eluted first, minimising the
possibilities of co-elution between matrix components and target analytes. The same principle applied
in the last quarter of the chromatographic run where strongly retained matrix components eluted.
These strategies were adopted to minimise any interference from the instant coffee premix matrix
which may lead to a significant ion suppression or ion enhancement of target analytes.
The chromatographic elution profile incorporated an extensive column re-equilibration segment in
the developed method. Immediately after conditioning at 34.01 minutes, the re-equilibrium time
was maintained at the initial gradient percentage for about 6 minutes by ramping up the flow rate to
1 mL/min. Consequently, the columnwas flushed with approximately five times of the column volume
before the next sample injection. Apart from achieving a good separation and a constant retention time
for all target analytes, quantitative variability was minimised, and the carry-over effect was not
observed in subsequent analysis. Besides, all four different groups of structural isomers were separated
down to a baseline level, ensuring the specificity of each target analyte as illustrates in Fig. 1.
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The first MS issue encountered during the method development phase was the presence of sodium
adducts, especially with analytes containing carbonyl groups. Although this phenomenon often
observed in previous studies, it has not been acknowledged and addressed. It is widely known that one
of the most common sources of this metal adduct contamination is the laboratory glassware [4].
Plasticware, therefore, was utilised throughout the whole experimental processes. High drying gas
temperature may also contribute to the formation of sodium adducts; thus, the temperature was
lowered from 350 C to 300 C. These approaches led to the absence of metal adducts, particularly
single charge sodium adducts.
All other MS source parameters were adjusted based on the flow- and compound-dependent
parameters. The flow-dependent source parameters, which include nebuliser pressure and drying
gas flow, were adjusted based on the flow rate of 0.4 mL/min. The compound-dependent source
parameters, i.e. capillary voltage, fragmentor voltage, and CE, were adjusted based on themass range of
m/z 100 to 1100. The continuous infusion of two reference masses viz. purine (m/z 121.050873) and
hexakis(1H, 1H, 3H-tetrafluoropropoxy)phosphazine (m/z 922.009798) during each chromatographic
run led to the mass accuracy of less than 2 ppm for [MþH]þ precursor ions and less than 5 ppm for
fragment ions.
2.5. Optimisation of sample preparation
Even though the chromatographic separation and MS conditions have been fully optimised, the
widely used dilute and shoot (D&S) technique initially applied on instant coffee premixes with either
methanol, acetonitrile, or in combination with ultrapure water often end up in severe and moderate
MEs for most target analytes. During the early stage of method development, methanol was chosen as
the solvent for the D&S technique on instant coffee premixes as it produced the least number of target
analytes exhibiting ME.
The optimisation of sample preparation was mainly evaluated based on the ME and extraction
recovery (RE) efficiency. As the D&S technique using methanol is very simple, a dilution approach was
further attempted to minimise any possible ME that may arise from the instant coffee premix matrix.
The matrix was assessed at three levels of dilution at 1:2, 1:10, and 1:100, while maintaining the
concentration of target analytes at low, medium, and high quality control (QC) levels.
As expected, the D&S technique at the lowest dilution level of 1:2 had caused severe and moderate
ionisation suppressions for three and seven analytes, respectively. Even at 1:10 dilution, severe MEs
were still prominent for the same three analytes that belong to the acetyl-bonded analogue of sil-
denafil. The MEs for the D&S technique were found to be reduced in proportion to the matrix dilution
and turn out to be insignificant at 1:100 dilution. However, onemajor concern at this dilution level was
the ability of the developed procedure to detect target analytes at trace concentrations.
Consequently, another sample extraction technique was assessed in a review of the first attempted
D&S technique. The quick, easy, cheap, effective, rugged, and safe (QuEChERS) extraction technique
was selected primarily based on its time-saving advantage of sample preparation. To the best of our
knowledge, only two previous studies had employed the AOAC official 2007.01 QuEChERS method to
determine PDE5 inhibitors in herbal dietary supplements [5] and in Chinese tonic liquors [6]. On the
contrary, in this study, the EN 15662 QuEChERS salts were chosen due to its claimed capacity in
removing polar interferences, sugars, and fats that might be present in the sample matrix. Unfortu-
nately, the official buffered EN 15662 method using acetonitrile and hydrated instant coffee premix
give rise to poor RE for some target analytes. Therefore, several modified QuEChERS procedures were
attempted on a trial-and-error basis with varying solvent mixtures, sample loads and QuEChERS salts
quantities. The final methodology is given in detail in Section Sample preparation.
The modified QuEChERS extraction procedure was also evaluated at three dilution levels like the
D&S technique discussed above. The instant coffee premix matrix at 1:10 dilution exhibited an
insignificant ME for all target analytes with the percentage of within 5.22 to þ8.67. Equally, the RE
proved to be excellent for all target analytes at low, medium, and high QC levels within ±25% except for
N-desethylacetildenafil at low (53.8%) and medium (65.1%) QC levels. The analysis of real samples had
A.Y. Mohd Yusop et al. / Data in brief 25 (2019) 1042348evinced that any trace analyte was highly unlikely to produce false negative identification at this
dilution level as opposed to a higher level of dilution. Table 1 displays the comparison of the ME for all
23 targeted PDE5 inhibitors using the D&S technique with methanol against the modified QuEChERS
procedure on the instant coffee premix at different dilution levels.
2.6. Method validation
The analytical method validation was performed in accordance with the described procedure in
Section Method validation of Ref. [1]. The data on each validation parameter are presented in Tables
2e4
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